A SECRETORY MYELOMA IN A RENAL-TRANSPLANT RECIPIENT

We report the diagnostic and therapeutic problems of a patient who developed an asecretory, widely metastatic myeloma 4 years after renal transplantation. B-cell lymphoproliferative disorders are well-described in the setting of organ transplantation but the occurrence of myeloma is decidedly rare. While the nature of the association between this patient's myeloma and the immunosuppressive regimen received is unclear, the history of clinical transplantation suggests that clinicians may be faced with changing patterns of neoplasia with advances in immunosuppression.